Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Analysis of Real-World Data on Overall Survival in Multiple Myeloma Patients With =3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiD.
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
Interpretation and Utility of Novel Composite Structural Endpoints of Cumulative Damage and Disease Activity in Knee Osteoarthritis
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
Loke YK, Jeevanantham V, Singh S. Bisphosphonates and atrial fibrillation: systematic review and meta-analysis. Drug Saf. 2009; 32(3):219-28.
View in:
PubMed
subject areas
Administration, Oral
Atrial Fibrillation
Bone Density Conservation Agents
Cardiovascular Diseases
Diphosphonates
Humans
Osteoporosis
Randomized Controlled Trials as Topic
Risk Assessment
Stroke
authors with profiles
Sonal Singh MD, MPH